Breakthrough Rice Bran Nanoparticles Show Promise as Affordable and Targeted Anticancer Agent

2 years ago

Researchers discover that nanoparticles derived from rice bran are both effective and safe for the treatment of cancer Several types…

Cloud DX Will Report Fiscal Year 2023 Results and Hold Earnings Call on April 29, 2024

2 years ago

KITCHENER, ON / ACCESSWIRE / April 22, 2024 / Cloud DX Inc. (TSXV:CDX)(OTCQB:CDXFF) will post its FY2023 financial results after…

CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity

2 years ago

Live video webcast with Chief Executive Officer, John Climaco, on Tuesday, April 23rd at 12:00 PM ETHOUSTON, TX / ACCESSWIRE…

GE HealthCare’s MIM Software collaborates with Elekta to help enhance radiation therapy treatments and improve patient outcomes

2 years ago

Collaboration has always been important in the healthcare industry, but in this era of digital health, teamwork across institutions has…

Quest International Elevates Data Security Standards by Upgrading ISO 27001:2013 Certification to ISO 27001:2022

2 years ago

IRVINE, CA / ACCESSWIRE / April 22, 2024 / Quest International, the global aftermarket service support partner for Healthcare and…

Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS) Congress in Support of Company’s Expanding Focus on Cancer Supportive Care

2 years ago

Jaguar planning to begin commercial launch of FDA-approved Gelclair® prescription gel for oral mucositis (also called “chemo mouth”) in Q3…

Report: Employers Unaware of Ethical, Safety Implications of Health Insurance ‘Alternative Funding Programs’

2 years ago

Survey of human resource professionals finds most respondents lack understanding of the misuse of charitable programs and risks of requiring…

Lindis Blood Care Announces Positive Top-Line Results from Clinical Certification Study REMOVE with CATUVAB(R) to Enable Autologous Blood Transfusions in Cancer Surgeries

2 years ago

CATUVAB® procedure enables highly effective removal of malignant cells from intraoperative blood. All clinical endpoints met with high statistical significance.Convincing…

FSD Pharma Provides Another Update on Celly Nu’s Anticipated Launch of unbuzzd(TM)

2 years ago

TORONTO, ON / ACCESSWIRE / April 22, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way…